Loading
Latest filing published 02 Nov 2017 for The Canadian Bioceutical Corporation.
No signal scores available.
Only one filing by Robert R. Galvin is known so far (2 November 2017): a transaction, in The Canadian Bioceutical Corporation. That is too little to draw conclusions. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.